Ticker: HRTX

Heron Therapeutics, Inc. (NASDAQ: HRTX) - Q2 2025 Overview Heron Therapeutics focuses on improving patient outcomes through innovative medicines, particularly in managing pain and nausea associated with surgeries and chemotherapy. The company has recently reported its Q2 2025 earnings, highlighti...

Company Overview: Heron Therapeutics, Inc. (NASDAQ: HRTX) is a biotechnology company focused on developing and commercializing therapeutic innovations to enhance medical care, particularly in areas such as postoperative pain management and chemotherapy-induced nausea and vomiting. Recent Developm...